Related Experiment Videos
The epidemiology and genetics of congenital heart disease
1Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. goldmuntz@chop.edu
Insights
Congenital heart disease (CHD) has diverse genetic causes, often making diagnosis challenging. Ongoing research aims to improve genetic testing, family counseling, and clinical management for better patient outcomes.
Area of Science:
- Cardiology
- Genetics
- Developmental Biology
Background:
- Congenital heart disease (CHD) represents a significant category of major malformations.
- The genetic underpinnings of specific CHD lesions are notably heterogeneous.
- Different CHD types can arise from identical chromosomal alterations or mutations within the same gene.
Purpose of the Study:
- To summarize current understanding of the genetic causes of CHD.
- To highlight the limitations in current genetic diagnostic capabilities for CHD.
- To underscore the potential of future research in advancing CHD diagnosis and management.
Main Methods:
- Review and synthesis of existing studies on the genetic etiology of CHD.
- Analysis of the current availability and limitations of clinical genetic diagnostic tests for CHD.
- Discussion of the implications of genetic research for clinical practice and family counseling.
Main Results:
- The genetic cause of CHD is highly heterogeneous, with varied genetic alterations leading to similar or different cardiac malformations.
- Clinical genetic testing for CHD is currently limited, primarily available for cases with abnormal karyotypes or 22q11 deletion.
- Predicting mutation significance and developing large-scale screening technologies are necessary for broader genetic test availability.
Conclusions:
- Continued research into the genetic causes of CHD is crucial for understanding cardiac development.
- Advances in genetic research will improve recurrence risk counseling for families.
- Future insights will enable genotype-guided clinical management and early interventions to mitigate cardiac maldevelopment.
Abstract:
The studies summarized demonstrate that CHD is a common, major malformation. The genetic cause of each specific lesion is heterogeneous. In addition, different types of CHD can result from the same chromosomal alteration or from mutations in the same gene. Although one might predict that genotype influences clinical outcome, further studies are required. At this time, routine clinical diagnostic tests to identify the specific genetic cause are available in only a few cases, namely, those with abnormal karyotypes or those with a 22q11 deletion. In those cases with single-gene defects, genetic testing is not clinically available at this time and most likely will not become available until we can predict the significance of each mutation and until technologic advances are made that allow for large-scale, accurate screening. In the meantime, continued research on the genetic cause of CHD promises to augment our understanding of the mechanisms underlying the normal and abnormal development of the cardiac structures. These investigations also promise to augment our ability to counsel families on the recurrence risk with greater accuracy and, in the future, will allow the physician to modify his or her clinical management based on genetic cause. Finally, identifying the cause and understanding the disease mechanism allows for early intervention that may modify the degree of cardiac maldevelopment or avoid cardiac malformation altogether.